Riskpilot← Back to searchSign inGet full accessVALMED A/S
A/SActiveCVR 26985358Bredgade 30Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20033 employeesvalmed.dk
Revenue 2025
DKK 2,4M
+3% vs 2024
EBITDA margin
32.8%
+13% vs 2024
Equity ratio
15.7%
Financial strength
Net profit 2025
DKK 342K
+12% vs 2024
| Revenue | DKK 2,4M | +3% |
| EBITDA | DKK 795K | +13% |
| Net profit | DKK 342K | +12% |
| Total assets | DKK 8,2M | +24% |
| Equity | DKK 1,3M | +3% |
| Employees | 3 | — |
Legal name
VALMED A/S
CVR number
26985358
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31. januar 2003
Share capital
DKK 500.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af bestyrelsesformanden og direktøren i forening.
Company purpose
Selskabets formål er at drive handel og produktion
Address
Bredgade 30
Phone
+4545702015
Email
ab@valmed.dk
Website
valmed.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.558 | 1.799 | 1.869 | 1.660 | 1.501 | 1.392 | 1.566 | 1.826 | 2.491 | 2.283 | 2.016 | 2.036 | 2.355 | 2.423 |
| Staff expenses | -1.259 | -1.297 | -1.368 | -1.427 | -1.100 | -1.017 | -1.150 | -1.554 | -1.508 | -1.610 | -1.601 | -1.607 | -1.648 | -1.628 |
| EBITDA | 299 | 502 | 501 | 233 | 401 | 374 | 416 | 272 | 982 | 673 | 415 | 430 | 707 | 795 |
| Depreciation & amort. | -4 | 14 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -28 | -28 | -28 | -3 | -27 |
| EBIT | 295 | 488 | 501 | 233 | 401 | 374 | 416 | 272 | 982 | 645 | 388 | 402 | 703 | 769 |
| Net financials | -25 | -12 | -49 | -170 | -67 | -46 | -64 | -90 | -143 | -90 | -144 | -331 | -310 | -326 |
| Profit before tax | 271 | 475 | 451 | 63 | 334 | 328 | 351 | 182 | 840 | 556 | 243 | 70 | 393 | 443 |
| Tax | 87 | 119 | 118 | 26 | 81 | 79 | 84 | 41 | 187 | 124 | 55 | 16 | 89 | 101 |
| Net profit | 184 | 357 | 333 | 38 | 254 | 249 | 268 | 141 | 653 | 432 | 188 | 54 | 304 | 342 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.636 | 2.143 | 4.186 | 3.689 | 3.755 | 3.738 | 3.125 | 3.499 | 5.288 | 5.926 | 7.371 | 5.375 | 6.569 | 8.160 |
| Equity | 1.161 | 1.318 | 1.301 | 989 | 1.243 | 1.192 | 1.210 | 1.083 | 1.594 | 1.374 | 1.130 | 996 | 1.246 | 1.284 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 13 | 14 | 12 | 6 | -6 | 0 | 0 |
| Short-term debt | 1.461 | 826 | 2.885 | 2.700 | 2.511 | 2.538 | 1.906 | 2.410 | 3.686 | 4.546 | 6.241 | 4.379 | 5.323 | 6.874 |
| Total debt | 1.461 | 826 | 2.885 | 2.700 | 2.511 | 2.538 | 1.906 | 2.410 | 3.686 | 4.546 | 6.241 | 4.379 | 5.323 | 6.874 |
EBITDA margin
32.8%
This company
15.8%
Market median
+108% vs market
20122025
Equity ratio
15.7%
This company
38.2%
Market median
-59% vs market
20122025
Return on equity
26.7%
This company
18.4%
Market median
+45% vs market
20122025
Net profit margin
14.1%
This company
8.1%
Market median
+74% vs market
20122025
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20122025
Debt / equity
5.35×
This company
0.62×
Market median
-763% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OR Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
AB Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Chairman | 2004 | — | — | |
| Chairman | 2018 | — | — | |
| Chairman | 2006 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Al Goa Holding ApS | Company | 66.7% | 66.7% | 2018 |
SCHIERBECK E-CONSULT ApS | Company | 25.0% | 25.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Al Goa Holding ApS
VALMED A/S Board members of VALMED A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Rom Andersen | Chief Executive Officer | 0 companies |
| Anders Berg | Chief Executive Officer | 0 companies |
| Jesper Klaus Schierbeck-Hansen | Board of Directors | 0 companies |
| Lars Ballieu Christensen | Chairman | 0 companies |
| Christian Holst | Chairman | 0 companies |
| Helen Hanako Schierbeck-Hansen | Chairman | 0 companies |
| Tina Rytter Andersen | Chairman | 0 companies |
| Bent Rasmus Hansen | Board of Directors | 0 companies |